|
Sign In to gain access to subscriptions and/or personal tools.
|
Potentiation of Inhaled Staphylococcal Enterotoxin B-Induced Toxicity by Lipopolysaccharide in Mice
Ross D. Leclaire
Toxinology, United States Army Medical Research Institute of Infectious Diseases
Robert E. Hunt
Toxinology, United States Army Medical Research Institute of Infectious Diseases
Sina Bavari
Toxinology, United States Army Medical Research Institute of Infectious Diseases
James E. Estep
Applied Research
Gene O. Nelson
Biometrics
Catherine L. Wilhelmsen
Pathology Divisions, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 27702-5011
Nonhuman primates are the established model for evaluating toxic responses to staphylococcal enterotoxins (SEs), as they react similarly to humans. Rodents are generally considered unresponsive to SEs. Binding affinities and T-cell reactivity suggest that SE binds more efficiently to primate major histocompatability complex class II receptors than to mouse receptors. We investigated the potentiation of staphylococcal enterotoxin B (SEB) inhalation toxicity by lipopolysaccharide (LPS) in BALB/c mice. Lethality occurred only when SEB was potentiated by LPS. Neither SEB nor LPS produced lethal effects alone. Temporal responses of interleukin 1 , tumor necrosis factor , interleukin 2, and interferon- evoked by inhaled SEB were enhanced by LPS. By 24 hr after intoxication, serum cytokines decreased to baseline levels, and consistent pulmonary perivascular leukocytic infiltrates were evident histologically. Histologic lesions induced by inhalation exposure to SEB by mice, with or without potentiation by LPS, were similar to those in the rhesus monkey. Predominant pulmonary lesions included severe, diffuse interstitial and alveolar pulmonary edema, leukocytic infiltrates, mild perivascular edema, and alveolar fibrin deposition. Although the mechanism of aerosolized SEB-induced toxicity has not been completely resolved, similarities in histologic lesions, cytokine responses, and acute dose-response suggest the LPS-potentiated mouse model may be a credible alternative to the nonhuman primate model.
Key Words: Superantigen inhalation pulmonary edema shock mouse nonhuman primate
Toxicologic Pathology, Vol. 24, No. 5,
619-626 (1996)
DOI: 10.1177/019262339602400513

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. J. Roy, K. L. Warfield, B. C. Welcher, R. F. Gonzales, T. Larsen, J. Hanson, C. S. David, T. Krakauer, and S. Bavari
Human Leukocyte Antigen-DQ8 Transgenic Mice: a Model To Examine the Toxicity of Aerosolized Staphylococcal Enterotoxin B
Infect. Immun.,
April 1, 2005;
73(4):
2452 - 2460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Pedras-Vasconcelos, Y. Chapdelaine, R. Dudani, H. van Faassen, D. K. Smith, and S. Sad
Mycobacterium bovis BCG-Infected Mice Are More Susceptible to Staphylococcal Enterotoxin B-Mediated Toxic Shock than Uninfected Mice despite Reduced In Vitro Splenocyte Responses to Superantigens
Infect. Immun.,
August 1, 2002;
70(8):
4148 - 4157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Hale, S. B. Margolin, T. Krakauer, C. J. Roy, and B. G. Stiles
Pirfenidone Blocks the In Vitro and In Vivo Effects of Staphylococcal Enterotoxin B
Infect. Immun.,
June 1, 2002;
70(6):
2989 - 2994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Stiles, A. R. Garza, R. G. Ulrich, and J. W. Boles
Mucosal Vaccination with Recombinantly Attenuated Staphylococcal Enterotoxin B and Protection in a Murine Model
Infect. Immun.,
April 1, 2001;
69(4):
2031 - 2036.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|